DNMT3A and acute myeloid leukemia: The 160 CpG sites that were hypomethylated in DNMT3A-mutated CHIP correlated with DNMT3A mutation status in AML (125 [94%] of 133 CpG sites present in both datasets, P = 4.1 × 10−13, χ2 test).